Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 5/20 | 0.56 |
| ▸ | RAB9A | P51151 | 5/20 | 0.56 |
| ▸ | MAPT | P10636 | 5/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | HTT | P42858 | 3/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.54 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.54 |
| ▸ | RELA | Q04206 | 2/20 | 0.54 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | APP | P05067 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | NQO1 | P15559 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26691830 | 0.91 | NPC1 (0.51) | CYP1A2CYP3A4CYP2C19PDK1NPC1 | |
| SCHEMBL5857526 | 0.87 | NPC1 (0.54) | CYP1A2CYP3A4CYP2C19PDK1NPC1 | |
| Hydrochlorthiazide SCHEMBL9108846 | 0.87 | CYP1A2 (0.47) | CYP1A2CYP3A4CYP2C19PDK1NPC1 | |
| SCHEMBL12336473 | 0.85 | CYP3A4 (0.60) | CYP1A2CYP3A4CYP2C19NPC1RAB9A | |
| SCHEMBL8125517 | 0.85 | APP (0.54) | CYP1A2CYP3A4CYP2C19PDK1MAPT | |
| SCHEMBL21412546 | 0.84 | CYP1A2 (0.59) | CYP1A2CYP3A4CYP2C19PDK1NPC1 | |
| SCHEMBL12312877 | 0.84 | CYP3A4 (0.46) | CYP1A2CYP3A4CYP2C19PDK1NPC1 | |
| SCHEMBL8773253 | 0.82 | CA2 (0.46) | CYP1A2CYP3A4CYP2C19PDK1NPC1 | |
| SCHEMBL26691755 | 0.81 | RAB9A (0.42) | CYP1A2CYP3A4CYP2C19PDK1NPC1 | |
| SCHEMBL26691761 | 0.81 | RAB9A (0.43) | CYP1A2CYP3A4CYP2C19PDK1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118955457-A | Chemiluminescent probe compound and application thereof | 广州中医药大学(广州中医药研究院) | 2024-11-15 | — | — | CN | claimed |
| EP-0527186-A4 | — | UNIV ILLINOIS (US) | 1995-01-18 | — | — | EP | claimed |
| EP-0527186-A1 | PHOTODYNAMIC PLANT DEFOLIANTS AND CHLOROPHYLL BIOSYNTHESIS MODULATORS | The Board of Trustees for the University of Illinois (US) | 1993-02-17 | — | — | EP | claimed |
| WO-1991016820-A1 | PHOTODYNAMIC PLANT DEFOLIANTS AND CHLOROPHYLL BIOSYNTHESIS MODULATORS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1991-11-14 | — | — | WO | claimed |
| US-5026426-A | Ink compositions having improved waterfastness | HEWLETT-PACKARD COMPANY (US) | 1991-06-25 | — | — | US | claimed |
| JP-11332593-A | — | — | None | — | — | JP | disclosed |
| US-20260028334-A1 | N-(3-(BENZO[B]THIOPHENE-2-CARBOXAMIDO)-PHENYL)-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS LACTATE/ATP PRODUCTION INHIBITORS FOR THE TREATMENT OF CANCER | WMT AG (DE) | 2026-01-29 | — | — | US | disclosed |
| CN-118955457-A | Chemiluminescent probe compound and application thereof | 广州中医药大学(广州中医药研究院) | 2024-11-15 | — | — | CN | disclosed |
| CN-118974040-A | N- (3- (benzo [ B ] thiophen-2-amido) -phenyl) -2, 3-dihydrobenzo [ B ] [1,4] dioxin-6-amide derivatives and related compounds as lactic acid/ATP production inhibitors for the treatment of cancer | 威马特股份公司 | 2024-11-15 | — | — | CN | disclosed |
| EP-3658544-B1 | DERIVATIVES OF LUCIFERIN AND METHODS FOR THEIR SYNTHESIS | UNIV CAPE TOWN (ZA) | 2024-07-31 | — | — | EP | disclosed |
| WO-2023194458-A1 | N-(3-(BENZO[B]THIOPHENE-2-CARBOXAMIDO)-PHENYL)-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS LACTATE/ATP PRODUCTION INHIBITORS FOR THE TREATMENT OF CANCER | WMT AG (DE) | 2023-10-12 | — | — | WO | disclosed |
| WO-2023275744-A1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | TECNIMEDE - Sociedade Técnico-medicinal, SA (PT) | 2023-01-05 | — | — | WO | disclosed |
| WO-1990000618-A1 | PREPARATION AND USE OF FLUORESCENT BENZOTHIAZOLE DERIVATIVES | JBL SCIENTIFIC, INC. (US) | 1990-01-25 | — | — | WO | disclosed |
| US-4882715-A | Surface acoustic wave convolver with dielectric film of high non-linear effect | CANON KABUSHIKI KAISHA (JP) | 1989-11-21 | — | — | US | disclosed |
| US-4826989-A | Process for the preparation of luciferin compounds | BOEHRINGER MANNHEIM GMBH (DE) | 1989-05-02 | — | — | US | disclosed |
| EP-0295145-A2 | Recording method and recording apparatus | CANON KABUSHIKI KAISHA (JP) | 1988-12-14 | — | — | EP | disclosed |
| EP-0284229-A1 | Nonlinear optical material and method for orientation thereof | CANON KABUSHIKI KAISHA (JP) | 1988-09-28 | — | — | EP | disclosed |
| EP-0282978-A2 | Surface acoustic wave convolver with dielectric film of high non-linear effect | CANON KABUSHIKI KAISHA (JP) | 1988-09-21 | — | — | EP | disclosed |
| EP-0024525-B1 | Process for the preparation of luciferin and its derivatives | Roche Diagnostics GmbH (DE) | 1982-06-30 | — | — | EP | disclosed |
| EP-0024525-A1 | Process for the preparation of luciferin and its derivatives | Roche Diagnostics GmbH (DE) | 1981-03-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028334-A1 | N-(3-(BENZO[B]THIOPHENE-2-CARBOXAMIDO)-PHENYL)-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS LACTATE/ATP PRODUCTION INHIBITORS FOR THE TREATMENT OF CANCER | LDHA, LDHB, SLC6A1 | CYP1A2 1372/4885CYP3A4 1486/4885CYP2C19 1940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.